Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
unless it's a falling knife
This is a patience game.
It looks like major MM manipulation here! No PR to account for the price run up, nor any PR to account for the pps crash. Some folks lost their shirt on this Chinese junk.
I think that once the acquisition/merger with Spirit gets the green light we'll see a 2x banger here.
That also "Drives the Point Home" to NEVER listen to another investor buy recommendations without first doing your own DD.
I think institutions are pushing the pps down and accumulating at this level. We'll see teens again by summer 2024 (or much sooner).
If I see 4, I'll average down again.
6.92 for me. I may average down on a deep dip.
I think 10 is an easy 12 month target (maybe 3 month). Fundamentals are very good. I suspect that the pps push downward is the result of institutions playing around so that they can accumulate 'in mass' at lower prices. JMHO
It's not a swing trade play. She will be at $10 within 6 months. JMHO
I am still LONG TERM "Bullish"
I am still LONG TERM "Bullish".......IF they don't do a R/S. Tim promised that he would never do a R/S. The question is... how good is his word and/or what would happen if he sold his business to another 3rd party. All bets are off then. For now, I'm bullish LT.
I am LONG TERM "Bullish".......IF they don't do a R/S.
At least this PR will result in RLFTF receiving REVENUES from the ACER partnership. It's prorgess.
https://relieftherapeutics.com/newsblog-detail/?newsID=2585961
I don't like the CEO.
R/S is the next chess move.
OK... what makes you think there will be lift off? I've been long this things for too long now.
Give it 1 year and this will be a 2x or 3x banger.
Just curious... what TA indicators do you mostly rely on? And what are your thoughts about this outfit --- https://basecamptrading.com/
Amazing !!
Minor (almost insignificant) mention of HOLO here.... https://markets.businessinsider.com/news/stocks/why-promis-neurosciences-shares-are-trading-higher-by-33-here-are-20-stocks-moving-premarket-1032572883
Whatever works! My best friend (army buddy) makes a good living out of his mancave using nothing but TA. Ain't broke don't fix it. He's got his trades down to the point it becomes boring for him. Two hours of trading in the A.M., and then he has the day off. But it took him 20 years to groom his trading skills to get to that point by studying and back testing thousands of charts. Whatever works! He only uses a small set of strategies at this point.
That doesn't answer my question. That's just the TA via. What is the FA view. Prices go up for a 'real' reason, not just because the technical indicators think it should. Relying 'solely' on charts and TA is not seeing the bigger picture. High risk. This is a china stock.... open for lots of MM manipulation.
So how is HOLO doing so well with NO press releases? Any insight into that?
ACER earnings out. Not was I was hoping for. Looks like they are out of money now.
https://finance.yahoo.com/news/acer-therapeutics-reports-second-quarter-200500038.html
It's a great company. EOM
Absolutely... yes. But that won't get our money back.
I'm a shareholder. I went long with this. I listened too much to - "you know who". For now I'm a stuckholder. Fortunately I did not bet the farm on this because I knew that I should do my own DD and I knew that I should diversify. Nevertheless, I'm a stuckholder hoping this will resurrect from the dead. There is some element of hope, now that the SEC is behind them. But it's a crapshoot at best.
Investors Beware. Some investors can be BULLISH one second, which lures in other investors. Then turn BEARISH on a dime. Do your on DD. Here is such an example (one of many). Buyers Beware!! JMHO
----------------------------------
Dragon Lady
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164018693
Re: cjstocksup post# 4695
Tuesday, May 25, 2021 1:53:49 PM
Post# 4697 of 13723
This is HUGE for QNTA shareholders!
May 22, 2021, the registrant had 176,458,527 shares of Common Stock outstanding.
You got it cj - it's a SPECTACULAR and almost unheard of LOW and LOW FLOAT share count for any OTC company !!
And this is the final POST MERGER NUMBER - which involved a large share issuance of approx 70 million, etc.
ALL NEW MGT from the MedoLife Rx merger (now fully completed) and they made it patently clear in the newly filed SEC 10-Q of today, "WE ARE CLEANING UP LEGACY PROBLEMS left by prior mgt team" etc.
That share count could DOUBLE IN THE NEXT YR - and STILL = a mega low floater and low share count for any growth company :)
Their A/S (available share count) is set at a paltry 500 million = they do NOT plan on massive dilution going forward !
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
This is old news. eom
Looks like JBLU is going to ALMOST hit is 'all time' low! Two years from now investors will be looking back at today price and feel sick that they didn't get in now.
I agree. They won't be able to sell shrooms to resurrect the business. Their cash balance is 3M (give or take some). So they are going to need to dilute to keep financing business operations and those salaries.
Lots of penny stocks (for lots of reasons) execute an r/s who are sitting at
356,287,674 O/S. Don't kid yourself.
I've always put RVVTF and RLFTF in the same category. Both are foreign entities (foreign to the FDA), both are tiny bitechs, neither has revenues, and both claimed to have a near-cure for COVID. So now here they are. Both are hovering between 2 and 3 cents a share. One recently had a devastating R/S, and I predict the other will have one on the near horizon.
MF is the Shroom King with misplaced priorities, and that is brought this company down. JMHO.
Uhh, News Flash.... the FDA rejected it thus far. I suspect that MF ran that PR as a pump/dump exercise which apparently failed. He needs to be creative in generating cash, and diluting at these low pps levels won't net much unless he is willing to drive the pps below a penny. I think MF is grasping at straws, and the r/s will happen out of necessity to raise cash. I have been burned in these exact situations several times, so I am speaking as a wounded warrior who had learned my lesson years ago. Never fall in love with a stock!!
Reverse Split TONIGHT (1 for 6). To avoid getting delisted. Ugly stuff!!!!!
Universe Pharmaceuticals INC Announces Share Consolidation
PDF Version
Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the “Share Consolidation”). As a result of the Share Consolidation, each six (6) pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.
The Share Consolidation will be effective at 5:00 p.m. Cayman Islands time on July 27, 2023. Beginning with the opening of trading on July 28, 2023, U.S. Eastern time, the Company’s ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Global Market under the same symbol “UPC” but under a new CUSIP number of G9442G 112. No fractional shares will be issued in connection with the Share Consolidation. All fractional shares will be rounded up to the whole number of shares. Immediately following the Share Consolidation, the authorized share capital of the Company will be US$3,125,000 divided into 150,000,000 ordinary shares, par value $0.01875 per share and 16,666,666.6666 preferred shares, par value $0.01875 per share.
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The Company also distributes and sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold in 30 provinces of China. For more information, visit the company’s website at http://www.universe-pharmacy.com/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” ”anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.
For more information, please contact:
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
Primary Logo
Source: Universe Pharmaceuticals INC
Have you taken notice that people are not dying from covid east cost to west coast (USA0) anymore. That only happened with Delta, and has significantly dropped off with the variants so much so that Joe B. declared an end to the COVID emergency. I think that the news has been out on that for quite some time. Maybe you missed it.
For the most part, FDA rules pertaining to EUA on covid treatments are back to pre-covid standards. RVVTF completley missed the boat on covid due to MF's obsession with Shrooms. I predict an r/s will soon be on the burner because MF needs more $ to finance his comp package. The guy is a phony.
White Choc.... I agree. At least 2 years ago multiple leading scientists announced that 'historically' viruses become weaker and weaker as they mutate over time. Hence, all of the talk about how the delta virus will eventually mutate and be treated as a common winter flu. This is exactly what happened.
And.... over that period of time standard of care (SOC) continued to improve. So biotech therapies during their FDA studies were constantly competing against improving SOC. IMO it was improving SOC is what took the legs out of most biotech FDA covid studies. As far as I could tell, most FDA studies for covid did not 100% decouple their primary endpoints from SOC. Investors who made a lot of $$ on the covid biotech sector did so by selling 'on the hype'. Those that lost $$ typically were those that held their shares down to the end (FDA trial completions).
Now RVVTF must dump/dilute more shares to keep paying their high compensation packages. The O/S and float will continue to grow. I now only see one undesirable outcome for this when MF and other officers realize that they need to re-energize this cash cow machine while they continue to pursue the DREAM of actually generating sales from a real product. Shroom sales just won't cut it IMO.
The patents are not worthless.